Cancer risk with folic acid supplements: A systematic review and meta-analysis

BMJ Open

Volumn 2, Issue 1, 2012, Pages

  Wien, Tale Norbye ^a   Pike, Eva ^a   Wisløff, Torbjørn ^a   Staff, Annetine ^b,c   Smeland, Sigbjørn ^b,c   Klemp, Marianne ^a  

^a NORWEGIAN KNOWLEDGE CENTRE FOR THE HEALTH SERVICES   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYANOCOBALAMIN; FOLIC ACID; MULTIVITAMIN; PLACEBO; PYRIDOXINE;

ATROPHIC GASTRITIS; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CARDIOVASCULAR DISEASE; COCHRANE LIBRARY; COLORECTAL ADENOMA; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; EMBASE; HUMAN; KIDNEY DISEASE; LUNG CANCER; MEDLINE; META ANALYSIS; PANCREAS CANCER; POSTMENOPAUSE; PROSTATE CANCER; REVIEW; SENSITIVITY ANALYSIS; SMOKING HABIT; SYSTEMATIC REVIEW; ULCERATIVE COLITIS;

EID: 84857805238     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2011-000653     Document Type: Review

References (67)

1. Avdeling for Legemiddelepidemiologi Divisjon for Epidemiologi Nasjonalt Folkehelseinstitutt. Drug Consumption in Norway 2005-2009. 2010. http://www.legemiddelforbruk.no/ (accessed 17 Mar 2011).
2. Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997;277:1775-81.
3. Clarke R, Halsey J, Lewington S, et al. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med 2010;170:1622-31.
4. Bazzano LA, Reynolds K, Holder KN, et al. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA 2006;296:2720-6. (Pubitemid 44917549)
5. Lee M, Hong KS, Chang SC, et al. Efficacy of homocysteine-lowering therapy with folic Acid in stroke prevention: a meta-analysis. Stroke 2010;41:1205-12.
6. Cuskelly GJ, Mooney KM, Young IS. Folate and vitamin B12: friendly or enemy nutrients for the elderly. Proc Nutr Soc 2007;66:548-58.
7. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity and the Prevention of Cancer: a Global Perspective. World Cancer Research Fund/American Institute for Cancer Research, 2007. http://www.dietandcancerreport.org/?p=er&JServSessionIdr004=jvchfng982. app244a
8. Duthie SJ. Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull 1999;55:578-92.
9. Prinz-Langenohl R, Fohr I, Pietrzik K. Beneficial role for folate in the prevention of colorectal and breast cancer. Eur J Nutr 2001;40:98-105. (Pubitemid 32963499)
10. Kim YI. Folate and colorectal cancer: an evidence-based critical review. Mol Nutr Food Res 2007;51:267-92.
11. Cole BF, Baron JA, Sandler RS, et al; Polyp Prevention Study Group. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007;297:2351-9. (Pubitemid 46883748)
12. Ebbing M, Bonaa KH, Nygard O, et al. Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA 2009;302:2119-26.
13. Bonaa KH, Njolstad I, Ueland PM, et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006;354:1578-88.
14. Ebbing M, Bleie O, Ueland PM, et al. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. JAMA 2008;300:795-804.
15. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009;6:e1000100.
16. Research Protocol: Cancer Risk With Folic Acid Supplements: A Systematic Review and Meta-Analysis. 2011. http://www.nokc.no. In press.
17. Cochrane Effective Practice and Organisation Filter of Care (EPOC) Group filter. In: Slik oppsummerer vi forskning. Håndbok for Nasjonalt kunnskapssenter for helsetjenesten 2009; Vedlegg 1: Tabeller med relevans for informasjonssøking. 2009. http://www.kunnskapssenteret.no. http://www.kunnskapssenteret.no/Verkt%C3%B8y/2139.cms (accessed 9 Apr 2011).
18. Cancer risk with folic acid supplements: a systematic review and meta-analysis. 2011. http://www.nokc.no. In press.
19. Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration. 2011. http://www.cochrane-handbook. org/ (accessed 29 May 2011).
20. Slik oppsummerer vi forskning. Håndbok for Nasjonalt kunnskapssenter for helsetjenesten 2009. 2009. http://www.kunnskapssenteret.no. http://www.kunnskapssenteret.no/Verkt%C3%B8y/2139.cms (accessed 9 Apr 2011).
21. Guyatt GH, Oxman AD, Kunz R, et al. What is "quality of evidence" and why is it important to clinicians? BMJ 2008;336:995-8. (Pubitemid 351656090)
22. Logan RF, Grainge MJ, Shepherd VC, et al. Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology 2008;134:29-38. (Pubitemid 350309319)
23. Wu K, Platz EA, Willett WC, et al. A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma. Am J Clin Nutr 2009;90:1623-31.
24. Jamison RL, Hartigan P, Kaufman JS, et al. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA 2007;298:1163-70. (Pubitemid 47403102)
25. Toole JF, Malinow MR, Chambless LE, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004;291:565-75. (Pubitemid 38500310)
26. Zhang SM, Cook NR, Albert CM, et al. Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial. JAMA 2008;300:2012-21.
27. Lonn E, Yusuf S, Arnold MJ, et al; Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006;354:1567-77.
28. Armitage JM, Bowman L, Clarke RJ, et al; Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA 2010;303:2486-94.
29. Charles D, Ness AR, Campbell D, et al. Taking folate in pregnancy and risk of maternal breast cancer. BMJ 2004;329:1375-6. (Pubitemid 39656357)
30. Charles DH, Ness AR, Campbell D, et al. Folic acid supplements in pregnancy and birth outcome: re-analysis of a large randomised controlled trial and update of Cochrane review. Paediatr Perinat Epidemiol 2005;19:112-24. (Pubitemid 40477232)
31. Zhu S, Mason J, Shi Y, et al. The effect of folic acid on the development of stomach and other gastrointestinal cancers. Chin Med J (Engl) 2003;116:15-19. (Pubitemid 36432714)
32. Freudenheim JL, Marshall JR, Vena JE, et al. Premenopausal breast cancer risk and intake of vegetables, fruits, and related nutrients. J Natl Cancer Inst 1996;88:340-8. (Pubitemid 26094240)
33. Stolzenberg-Solomon RZ, Chang SC, Leitzmann MF, et al. Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Clin Nutr 2006;83:895-904. (Pubitemid 44713156)
34. Maruti SS, Ulrich CM, White E. Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk. Am J Clin Nutr 2009;89:624-33.
35. Lashner BA, Provencher KS, Seidner DL, et al. The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology 1997;112:29-32. (Pubitemid 27008982)
36. Skinner HG, Michaud DS, Giovannucci EL, et al. A prospective study of folate intake and the risk of pancreatic cancer in men and women. Am J Epidemiol 2004;160:248-58. (Pubitemid 39006781)
37. Oaks BM, Dodd KW, Meinhold CL, et al. Folate intake, post-folic acid grain fortification, and pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Clin Nutr 2010;91:449-55.
38. Slatore CG, Littman AJ, Au DH, et al. Long-term use of supplemental multivitamins, vitamin C, vitamin E, and folate does not reduce the risk of lung cancer. Am J Respir Crit Care Med 2008;177:524-30. (Pubitemid 351442191)
39. Netherlands Trial Register. Vitamin B12 and Folic Acid Supplementation for Preventing Fractures in Elderly People. 2011. http://www.who.int/ictrp/en/. http://apps.who.int/trialsearch/Trial.aspx?TrialID=NTR1333 (accessed 21 May 2011).
40. Haukeland University Hospital. NORVIT and WENBIT - Long-term Follow-up (NORVIT-WENBIT). 2010. http://ClinicalTrials.gov. http://www.clinicaltrials.gov/ ct2/show/NCT00671346 (accessed 22 May 2011).
41. Figueiredo JC, Grau MV, Haile RW, et al. Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Natl Cancer Inst 2009;101:432-5.
42. Klein EA, Thompson IM Jr, Tangen CM, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011;306:1549-56.
43. The Alpha-Tocopherol BCCPSG. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.
44. Glynn SA, Albanes D, Pietinen P, et al. Colorectal cancer and folate status: a nested case-control study among male smokers. Cancer Epidemiol Biomarkers Prev 1996;5:487-94. (Pubitemid 26235013)
45. Johansson M, Relton C, Ueland PM, et al. Serum B vitamin levels and risk of lung cancer. JAMA 2010;303:2377-85.
46. Eussen SJ, Vollset SE, Igland J, et al. Plasma folate, related genetic variants, and colorectal cancer risk in EPIC. Cancer Epidemiol Biomarkers Prev 2010;19:1328-40.
47. Chuang SC, Stolzenberg-Solomon R, Ueland PM, et al. A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Eur J Cancer 2011;47:1806-16.
48. Larsson SC, Håkansson N, Giovannucci E, et al. Folate intake and pancreatic cancer incidence: a prospective study of Swedish women and men. J Natl Cancer Inst 2006;98:407-13.
49. Roswall N, Olsen A, Christensen J, et al. Source-specific effects of micronutrients in lung cancer prevention. Lung Cancer 2010;67:275-81.
50. Roswall N, Olsen A, Christensen J, et al. Micronutrient intake and risk of colon and rectal cancer in a Danish cohort. Cancer Epidemiol 2010;34:40-6.
51. Kim J, Kim DH, Lee BH, et al. Folate intake and the risk of colorectal cancer in a Korean population. Eur J Clin Nutr 2009;63:1057-64.
52. Baron JA, Sandler RS, Haile RW, et al. Folate intake, alcohol consumption, cigarette smoking, and risk of colorectal adenomas. J Natl Cancer Inst 1998;90:57-62. (Pubitemid 28078082)
53. Figueiredo JC, Levine AJ, Grau MV, et al. Colorectal adenomas in a randomized folate trial: the role of baseline dietary and circulating folate levels. Cancer Epidemiol Biomarkers Prev 2008;17:2625-31.
54. Tjønneland A, Christensen J, Olsen A, et al. Folate intake, alcohol and risk of breast cancer among postmenopausal women in Denmark. Eur J Clin Nutr 2006;60:280-6.
55. Shannon J, Phoutrides E, Palma A, et al. Folate intake and prostate cancer risk: a case-control study. Nutr Cancer 2009;61:617-28.
56. Roswall N, Olsen A, Christensen J, et al. Micronutrient intake and risk of urothelial carcinoma in a prospective Danish cohort. Eur Urol 2009;56:764-70.
57. Larsson SC, Giovannucci E, Wolk A. Folate and risk of breast cancer: a meta-analysis. J Natl Cancer Inst 2007;99:64-76.
58. Shanmugham JR, Zavras AI, Rosner BA, et al. Alcohol-folate interactions in the risk of oral cancer in women: a prospective cohort study. Cancer Epidemiol Biomarkers Prev 2010;19:2516-24.
59. Collin SM, Metcalfe C, Refsum H, et al. Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and metaanalysis. Cancer Epidemiol Biomarkers Prev 2010;19:1632-42.
60. Thompson JR, Fitz GP, Willoughby ML, et al. Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control study. Lancet 2001;358:1935-40. (Pubitemid 34072874)
61. Brække K, Staff AC. Periconceptional use of folic acid supplements in Oslo. Acta Obstet Gynecol Scand 2003;82:620-7. (Pubitemid 36735136)
62. Nilsen RM, Vollset SE, Gjessing HK, et al. Patterns and predictors of folic acid supplement use among pregnant women: the Norwegian Mother and Child Cohort Study. Am J Clin Nutr 2006;84:1134-41. (Pubitemid 44730385)
63. Ray JG, Meier C, Vermeulen MJ, et al. Association of neural tube defects and folic acid food fortification in Canada. Lancet 2002;360:2047-8. (Pubitemid 36026586)
64. Smeland S, Holven K, Løken EB, et al. Helsemessige gevinster av økt folatinntak. Hvordan nå ut til ønsket målgruppe? Norwegian Directorate of Health, 2007.
65. Galan P, Kesse-Guyot E, Czernichow S, et al; SU.FOL.OM3 Collaborative Group. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. BMJ 2010;341:c6273.
66. The Health and Social Care Information Centre. Statistics on Smoking, England 2006. 2011. http://www.ic.nhs.uk. http://www.ic.nhs.uk/statistics-and- data-collections/health-and-lifestyles/smoking/statistics-on-smoking-england- 2006 (accessed 2 Jun 2011).
67. Cochrane Public Health Group. Protocol Under Development: Fortification of Wheat and Maize Flour With Folic Acid for Population Health Outcomes. 2010. http://www.cochrane.org. http://www2.cochrane.org/reviews/en/title- 87197313613479766788100705065221.html (accessed 22 May 2011).